JP2008539258A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539258A5 JP2008539258A5 JP2008509091A JP2008509091A JP2008539258A5 JP 2008539258 A5 JP2008539258 A5 JP 2008539258A5 JP 2008509091 A JP2008509091 A JP 2008509091A JP 2008509091 A JP2008509091 A JP 2008509091A JP 2008539258 A5 JP2008539258 A5 JP 2008539258A5
- Authority
- JP
- Japan
- Prior art keywords
- tanaproget
- polymorph
- solution
- water
- concentrated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PYVFWTPEBMRKSR-UHFFFAOYSA-N tanaproget Chemical compound CN1C(C#N)=CC=C1C1=CC=C(NC(=S)OC2(C)C)C2=C1 PYVFWTPEBMRKSR-UHFFFAOYSA-N 0.000 claims 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 24
- 238000000034 method Methods 0.000 claims 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 12
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims 10
- 229950001471 tanaproget Drugs 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 4
- 238000010438 heat treatment Methods 0.000 claims 4
- 238000002441 X-ray diffraction Methods 0.000 claims 3
- 238000000113 differential scanning calorimetry Methods 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000001757 thermogravimetry curve Methods 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- BQMPGKPTOHKYHS-UHFFFAOYSA-N 1h-pyrrole-2-carbonitrile Chemical group N#CC1=CC=CN1 BQMPGKPTOHKYHS-UHFFFAOYSA-N 0.000 claims 1
- -1 4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl Chemical group 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 206010046798 Uterine leiomyoma Diseases 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 235000012631 food intake Nutrition 0.000 claims 1
- 238000002657 hormone replacement therapy Methods 0.000 claims 1
- 201000010260 leiomyoma Diseases 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000002632 myometrial effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67573705P | 2005-04-28 | 2005-04-28 | |
| PCT/US2006/015852 WO2006116526A2 (en) | 2005-04-28 | 2006-04-26 | Polymorph form ii of tanaproget |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013242731A Division JP2014088385A (ja) | 2005-04-28 | 2013-11-25 | タナプロゲットの精製形態ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008539258A JP2008539258A (ja) | 2008-11-13 |
| JP2008539258A5 true JP2008539258A5 (cg-RX-API-DMAC7.html) | 2009-06-04 |
Family
ID=36954854
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008509091A Pending JP2008539258A (ja) | 2005-04-28 | 2006-04-26 | タナプロゲットの精製形態ii |
| JP2013242731A Pending JP2014088385A (ja) | 2005-04-28 | 2013-11-25 | タナプロゲットの精製形態ii |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013242731A Pending JP2014088385A (ja) | 2005-04-28 | 2013-11-25 | タナプロゲットの精製形態ii |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7759341B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1874763A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2008539258A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101166736B (cg-RX-API-DMAC7.html) |
| AR (1) | AR053596A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006241125B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0610433A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2603807A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007013469A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200716621A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006116526A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004287875B2 (en) | 2003-11-05 | 2011-06-02 | Bausch + Lomb Ireland Limited | Modulators of cellular adhesion |
| US7767668B2 (en) * | 2005-04-28 | 2010-08-03 | Wyeth Llc | Micronized tanaproget, compositions, and methods of preparing the same |
| MX2007013469A (es) * | 2005-04-28 | 2008-01-22 | Wyeth Corp | Forma ii polimorfa de tanaproget. |
| WO2006116596A2 (en) * | 2005-04-28 | 2006-11-02 | Wyeth | Micronized tanaproget and compostions containing same |
| BRPI0610438A2 (pt) | 2005-04-28 | 2012-10-23 | Wyeth Corp | composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição |
| MX2007015571A (es) | 2005-06-09 | 2008-03-06 | Wyeth Corp | Composiciones de tanaproget que contienen etinilestradiol. |
| US20090170823A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception |
| US20110237605A1 (en) * | 2010-03-26 | 2011-09-29 | Eric Phillips | Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative |
| SI2861566T1 (sl) | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
| EP2877465A4 (en) | 2012-07-25 | 2016-05-11 | Sarcode Bioscience Inc | LFA-1 HEMMER AND POLYMORPH THEREOF |
| PL2900669T3 (pl) | 2012-09-25 | 2020-01-31 | F. Hoffmann-La Roche Ag | Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| AU2014356583B2 (en) | 2013-11-26 | 2019-02-28 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl |
| CR20160418A (es) | 2014-03-26 | 2016-11-07 | Hoffmann La Roche | Nuevos compuestos biciclicos de 7 eslabones |
| MA50635A (fr) | 2014-03-26 | 2020-08-12 | Hoffmann La Roche | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| EP3344619B1 (en) | 2015-09-04 | 2020-10-28 | H. Hoffnabb-La Roche Ag | Phenoxymethyl derivatives |
| AU2016328437A1 (en) | 2015-09-24 | 2018-01-25 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
| WO2017050747A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual atx/ca inhibitors |
| BR112018006080A2 (pt) | 2015-09-24 | 2018-10-09 | F. Hoffmann-La Roche Ag | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| RU2019132254A (ru) | 2017-03-16 | 2021-04-16 | Ф. Хоффманн-Ля Рош Аг | Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca |
| EP3596060B1 (en) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100732692B1 (ko) * | 1999-05-04 | 2007-06-27 | 와이어쓰 | 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체 |
| UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| EP1531824A4 (en) * | 2002-06-25 | 2005-09-21 | Wyeth Corp | CYCLOTHIOCARBAMATE DERIVATIVES AS PR-MODULATORS AND THEIR USE IN THE TREATMENT OF SKIN DISEASES |
| AU2003247608A1 (en) * | 2002-06-25 | 2004-01-06 | Wyeth | Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| US8399013B2 (en) * | 2003-06-26 | 2013-03-19 | Poly-Med, Inc. | Partially absorbable fiber-reinforced composites for controlled drug delivery |
| BRPI0510260A (pt) | 2004-04-27 | 2007-10-23 | Wyeth Corp | método para purificar um composto, e, kit farmacêutico |
| PA8631101A1 (es) | 2004-04-27 | 2006-09-08 | Wyeth Corp | Proceso de acoplamiento para la generacion de derivados reactivos de pirrol-2-carbonitrilo n-sustituidos con contenido de boro para producir biarilos |
| AU2005272854B2 (en) * | 2004-08-13 | 2012-04-26 | Wyeth | Tanaproget derivatives, metabolites, and uses thereof |
| BRPI0610438A2 (pt) | 2005-04-28 | 2012-10-23 | Wyeth Corp | composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição |
| ES2431324T3 (es) | 2005-04-28 | 2013-11-26 | Wyeth Llc | Forma purificada de tanaproget |
| WO2006116596A2 (en) | 2005-04-28 | 2006-11-02 | Wyeth | Micronized tanaproget and compostions containing same |
| US7767668B2 (en) | 2005-04-28 | 2010-08-03 | Wyeth Llc | Micronized tanaproget, compositions, and methods of preparing the same |
| MX2007013469A (es) | 2005-04-28 | 2008-01-22 | Wyeth Corp | Forma ii polimorfa de tanaproget. |
| MX2007015571A (es) | 2005-06-09 | 2008-03-06 | Wyeth Corp | Composiciones de tanaproget que contienen etinilestradiol. |
-
2006
- 2006-04-25 MX MX2007013469A patent/MX2007013469A/es active IP Right Grant
- 2006-04-25 CN CN2006800142218A patent/CN101166736B/zh not_active Expired - Fee Related
- 2006-04-25 BR BRPI0610433-9A patent/BRPI0610433A2/pt not_active IP Right Cessation
- 2006-04-26 TW TW095114816A patent/TW200716621A/zh unknown
- 2006-04-26 US US11/412,015 patent/US7759341B2/en not_active Expired - Fee Related
- 2006-04-26 AR ARP060101668A patent/AR053596A1/es not_active Application Discontinuation
- 2006-04-26 JP JP2008509091A patent/JP2008539258A/ja active Pending
- 2006-04-26 EP EP06751521A patent/EP1874763A2/en not_active Withdrawn
- 2006-04-26 AU AU2006241125A patent/AU2006241125B2/en not_active Ceased
- 2006-04-26 CA CA002603807A patent/CA2603807A1/en not_active Abandoned
- 2006-04-26 WO PCT/US2006/015852 patent/WO2006116526A2/en not_active Ceased
-
2010
- 2010-06-03 US US12/792,978 patent/US7968709B2/en not_active Expired - Fee Related
-
2011
- 2011-05-12 US US13/106,494 patent/US8114869B2/en not_active Expired - Fee Related
-
2012
- 2012-01-10 US US13/347,080 patent/US20120115858A1/en not_active Abandoned
-
2013
- 2013-11-25 JP JP2013242731A patent/JP2014088385A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI704142B (zh) | 抗癌劑1-((4-(4-氟-2-甲基-1h-吲哚-5-基氧基)-6-甲氧基喹啉-7-基氧基)甲基)環丙胺的製備方法、及其藥物的結晶形及其鹽類 | |
| CN102625797B (zh) | 作为激酶抑制剂的取代杂环化合物及其使用方法 | |
| TW201238951A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| JP3665053B2 (ja) | 純結晶形態の5−クロロ−3−(4−メタンスルホニルフェニル)−6’−メチル−[2,3’]ビピリジニルおよび合成方法 | |
| JP2016155832A (ja) | エストロゲン受容体モジュレーターおよびその使用 | |
| CN111393431A (zh) | 谷氨酰胺酶抑制剂 | |
| JP2012508719A (ja) | スニチニブマレートの新たな結晶形 | |
| JP2023157909A (ja) | 2-(5-(4-(2-モルホリノエトキシ)フェニル)ピリジン-2-イル)-n-ベンジルアセトアミドの固体形態 | |
| WO2006116526A8 (en) | Polymorph form ii of tanaproget | |
| JP2018537486A (ja) | キノロン類似体及びその塩の結晶形 | |
| TW202444341A (zh) | 萘胺類粒線體自噬誘導劑的固體形式、其製備方法、藥物組合物和用途 | |
| JP2026041824A (ja) | テガビビントの結晶形態、調製方法、及びその使用 | |
| TW201422594A (zh) | 結晶化合物 | |
| WO2022134147A1 (zh) | 一种化合物及利用其制备取代的[5,6]环-4(3h)-嘧啶酮化合物的方法 | |
| CA2447878C (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| CN101921260B (zh) | 一种伊马替尼的制备方法 | |
| TW202024078A (zh) | Bet溴結構域(bromodomain)抑制劑之固體形式之製備方法 | |
| JP2022500433A5 (cg-RX-API-DMAC7.html) | ||
| EP4143182B1 (en) | Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitors | |
| WO2013013595A1 (zh) | 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的结晶物及其制备方法 | |
| TWI855259B (zh) | 用作激酶抑制劑的化合物及其用途 | |
| JP2021512893A5 (cg-RX-API-DMAC7.html) | ||
| JP2018525436A (ja) | オービットアジン−フマル酸塩、水和物、結晶形及びその調製方法 | |
| TW202233596A (zh) | 作為parp抑制劑之新型化合物 | |
| HK40090290A (en) | Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitors |